Review
doi: 10.1007/s004670100582.
Pathophysiology and treatment of IgA nephropathy in children
Affiliations
- PMID: 11405121
- DOI: 10.1007/s004670100582
Item in Clipboard
Review
Pathophysiology and treatment of IgA nephropathy in children
Pediatr Nephrol.
2001 May.
Abstract
IgA nephropathy is the most-common primary glomerulonephritis worldwide, and about 20%-50% of patients develop progressive renal failure. The pathogenesis is still unknown and treatment has not yet been established. Knowledge concerning childhood IgA nephropathy has expanded greatly in the last 10 years, and its importance as the major form of glomerulonephritis and major contributor to end-stage renal disease is also becoming apparent in children. This review focuses on the pathophysiology and treatment of IgA nephropathy in children.
Comment in
-
Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy.Pediatr Nephrol. 2002 Apr;17(4):302-4. doi: 10.1007/s00467-002-0829-y. Pediatr Nephrol. 2002. PMID: 11956889 No abstract available.
Similar articles
-
[Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].Zhonghua Er Ke Za Zhi. 2015 Sep;53(9):670-5. Zhonghua Er Ke Za Zhi. 2015. PMID: 26757967 Chinese.
-
[Glomerulonephritis with IgA mesangial deposits].Nephrol Ther. 2010 Nov;6(6):545-57. doi: 10.1016/j.nephro.2010.03.007. Epub 2010 Apr 15. Nephrol Ther. 2010. PMID: 20399170 French.
-
IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?Am J Med. 1988 Jan;84(1):129-32. doi: 10.1016/0002-9343(88)90019-8. Am J Med. 1988. PMID: 3337116
-
The pathogenetic aspects and gene polymorphisms of IgA nephropathy.Prague Med Rep. 2006;107(2):171-88. Prague Med Rep. 2006. PMID: 17066738 Review.
-
IgA nephropathy.Curr Opin Pediatr. 1999 Apr;11(2):152-7. doi: 10.1097/00008480-199904000-00009. Curr Opin Pediatr. 1999. PMID: 10202625 Review.
Cited by
-
IgA nephropathy with presentation of nephrotic syndrome at onset in children.Pediatr Nephrol. 2017 Mar;32(3):457-465. doi: 10.1007/s00467-016-3502-6. Epub 2016 Oct 6. Pediatr Nephrol. 2017. PMID: 27714465
-
Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.Pediatr Nephrol. 2015 Jul;30(7):1121-9. doi: 10.1007/s00467-014-3041-y. Epub 2015 Mar 15. Pediatr Nephrol. 2015. PMID: 25773534 Free PMC article.
-
Serum IgA/C3 ratio and glomerular C3 staining predict progression of IgA nephropathy in children.Transl Pediatr. 2021 Mar;10(3):666-672. doi: 10.21037/tp-21-90. Transl Pediatr. 2021. PMID: 33880336 Free PMC article.
-
Health-related quality of life in children with immunoglobulin A nephropathy - results of a multicentre national study.Arch Med Sci. 2020 Nov 24;17(1):84-91. doi: 10.5114/aoms.2020.100367. eCollection 2021. Arch Med Sci. 2020. PMID: 33488859 Free PMC article.
-
Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy.Pediatr Nephrol. 2015 Jul;30(7):1113-20. doi: 10.1007/s00467-014-3024-z. Epub 2014 Dec 31. Pediatr Nephrol. 2015. PMID: 25549975
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
